LMR Partners’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SMMT
BBA
KCM
LMR Partners's SMMT Position: Q3 2026 in Review
LMR Partners sold out of Summit Therapeutics (SMMT) in Q3 2026, closing a stake of 96,177 shares — an estimated $1.44M sold.
LMR Partners first reported a position in SMMT in Q1 2021 and held it in 5 quarters. The position peaked at $1.4M in Q2 2026. 296 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.
- LMR Partners reported no remaining Summit Therapeutics position as of Q3 2026 after selling out during the quarter.
- LMR Partners sold 96,177 Summit Therapeutics shares in Q3 2026, an estimated $1.44M.
- LMR Partners first reported a position in Summit Therapeutics in Q1 2021 and held it in 5 quarters.
- LMR Partners's Summit Therapeutics position peaked at $1.4M in Q2 2026.
- 296 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.
Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.